{"nct_id":"NCT01943851","title":"A Dose Escalation Study to Investigate the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD) and Clinical Activity of GSK525762 in Subjects With Relapsed, Refractory Hematologic Malignancies","status":"COMPLETED","status_verified_date":"2024-09","start_date":"2014-05-14","start_date_type":"ACTUAL","primary_completion_date":"2020-04-30","primary_completion_date_type":"ACTUAL","completion_date":"2020-04-30","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}